EvodiaBio raised DKK 45 million in a funding round led by RA Capital Management, joined by EIFO, Francis Family Funds and Wild Radicals.
17 December 2025
17 December 2025
Total investments received (USD): 20.01M
Round value (USD): 6.97M
Company: Evodiabio
Related deals
Octarine Bio in a €5 million series A extension with DSM Venturing, Óskare Capital, The Footprint Fund, EIFO, Unconventional Ventures, Edaphon
Investments
23 December 2025
Fida Biosystems raised €5 million series A extension from EIFO and Swedish venture fund FSG
Investments
02 December 2025
Chromologics raised €7m from Novo, EIFO, Döhler Ventures, Collateral Good Ventures, and Synergetic.
Investments
01 November 2025
Belgium
Netherlands
Austria
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
France
Ireland
Portugal
Spain
United Kingdom